secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2022-09-22T23:59:59+00:00
Accession:  0001193125-22-249235
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience raises $72.5M in PIPE financing to extend cash runway into 2025
-------------------------------------------------------------------------------

- PIPE includes 3,373,526 shares at $12.50 and 2,426,493 pre-funded warrants at $12.4999 with $0.0001 exercise price.
- Gross proceeds ~$72.5M; expected close Sept. 26, 2022, subject to customary conditions.
- Management participated for ~$750,000; led by a life sciences fund with existing investors.
- Proceeds to fund PRECISION 1 trial, FYARRO commercial efforts, and general working capital.
- Cash runway expected into 2025; preliminary PRECISION 1 data anticipated in H1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/0001193125-22-249235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/d367672d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-249235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer